In the News
In the News
A new study found that living in a majority-Black neighborhood in Philadelphia is linked to increased maternal health issues. Mary Regina Boland, MA, MPhil, PhD, commented.
Susan Ellenberg, PhD, said that by the time most participants were vaccinated, there was less COVID-19 going around — possibly making the vaccines seem a bit more effective than they were.
Susan Ellenberg, PhD, commented on the purpose of the Vaccine Adverse Event Reporting System (VAERS) national early warning system: It collects reports that allow government scientists and others to rapidly detect unusual patterns that later can be analyzed.
Susan Ellenberg, PhD, discussed the risks of blood clots connected with the AstraZeneca COVID-19 vaccine and weighed whether it was necessary to suspend use.
Jeffrey Morris, PhD, told NBC10 that while he believes people should stay vigilant with mask-wearing and other precautions, he thinks that vaccines and warmer weather will prevent a large surge in cases.
“When you have the whole world working on something at the same time … the evidence evolves fast,” Meghan Brooks Lane-Fall, MD, MSHP, FCCM, commented about COVID-19 care. “Every time I take care of a COVID patient … I have to sit down and go, ‘OK, what are we doing now?’”
Susan Ellenberg, PhD, said some reports of post-vaccination symptoms may actually be unrelated to the COVID-19 vaccine. “Vaccines protect against one thing: the infection or the infection plus disease,” she commented.
Seeing a strange health occurence happen right after a vaccine is given can make it hard to believe that the vaccine did not cause the problem, commented Susan Ellenberg, PhD. “That temporal association just gets them every time.”
Susan Ellenberg, PhD, discussed how scientists were determining whether there was a connection between rare blood clots and AstraZeneca’s COVID-19 vaccine.
“People can make the argument: I volunteered to be in the trial…I should be able to get the vaccine right away even if I’m young and healthy,” Susan Ellenberg, PhD, commented.
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.